14th Annual International Pediatric Antimicrobial Stewardship Conference

Abstract Corresponding Author: Evan E. Facer, D.O. Washington University School of Medicine 660 S. Euclid Avenue MSC 8116-0043-10 St. Louis, MO 63110 314-286-1304 [email protected] Alternate Corresponding Author: Rebecca G. Same, M.D. Perelman School of Medicine at the University of Pennsylvania 3500 Civic Center Blvd Philadelphia, PA, 19104 [email protected] Funders: This supplement was sponsored by The Washington University School of Medicine. Conflicts of Interest: Evan E. Facer, DO Potential Conflicts of Interest: Dr. Facer received support from AbbVie, Inc. to characterize use of ceftazidime-avibactam in children. Jason G. Newland, MD, MEd Potential Conflicts of Interest: None Rebecca G. Same, MD Potential Conflicts of Interest: None INTRODUCTION We are pleased to present abstracts from the 14th Annual International Pediatric Antimicrobial Stewardship Conference, held May 29-31, 2024, in St. Louis, Missouri. This conference has grown markedly in both size and scope since the first meeting of 30 people in Kansas City, Missouri in 2010. This year, we hosted 200 attendees, in-person and virtually, and covered topics ranging from how breakpoints are established to environmental sustainability in healthcare. In addition to the main agenda, we were excited to again offer a pre-conference workshop, which focused on teamwork and leadership to prevent burnout in stewardship. We are proud to provide an opportunity for our fellows to share their research, and to learn from global leaders in antimicrobial stewardship as they share their efforts to combat antimicrobial resistance in resource-limited settings. Jason Newland founded and has led the stewardship conference since its inception. Despite its growth over time, it has retained his warmth, friendliness, and good humor. As Jason gradually transitions leadership of the conference into new hands, we are so grateful for his example and are honored to continue in the tradition that he started. Jason – thank you for building this collaborative, educational, and exceptionally fun meeting. We also want to thank the conference planning committee, Cindy Terrill, Lori Barganier, Michelle Padgett and the Washington University CME team, and The Pediatric Infectious Diseases Society for the support they provide to make this conference possible. The 15th Annual International Pediatric Antimicrobial Stewardship Conference will be held May 28-30, 2025, in St. Louis, Missouri. We hope to see you then! Evan E. Facer, DO, St. Louis Children’s Hospital, St. Louis, MO; Jason G. Newland, MD, MEd, Nationwide Children’s Hospital, Columbus, OH; Rebecca G. Same, MD, Children’s Hospital of Philadelphia, PA

Publication Details

Journal
Journal of the Pediatric Infectious Diseases Society
Published
2024-10-01
DOI
https://doi.org/10.1093/jpids/piae088.001
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

14th Annual International Pediatric Antimicrobial Stewardship Conference

Journal of the Pediatric Infectious Diseases Society
Antibiotic Use and Resistance
article

14th Annual International Pediatric Antimicrobial Stewardship Conference

article en

Abstract

Abstract Corresponding Author: Evan E. Facer, D.O. Washington University School of Medicine 660 S. Euclid Avenue MSC 8116-0043-10 St. Louis, MO 63110 314-286-1304 [email protected] Alternate Corresponding Author: Rebecca G. Same, M.D. Perelman School of Medicine at the University of Pennsylvania 3500 Civic Center Blvd Philadelphia, PA, 19104 [email protected] Funders: This supplement was sponsored by The Washington University School of Medicine. Conflicts of Interest: Evan E. Facer, DO Potential Conflicts of Interest: Dr. Facer received support from AbbVie, Inc. to characterize use of ceftazidime-avibactam in children. Jason G. Newland, MD, MEd Potential Conflicts of Interest: None Rebecca G. Same, MD Potential Conflicts of Interest: None INTRODUCTION We are pleased to present abstracts from the 14th Annual International Pediatric Antimicrobial Stewardship Conference, held May 29-31, 2024, in St. Louis, Missouri. This conference has grown markedly in both size and scope since the first meeting of 30 people in Kansas City, Missouri in 2010. This year, we hosted 200 attendees, in-person and virtually, and covered topics ranging from how breakpoints are established to environmental sustainability in healthcare. In addition to the main agenda, we were excited to again offer a pre-conference workshop, which focused on teamwork and leadership to prevent burnout in stewardship. We are proud to provide an opportunity for our fellows to share their research, and to learn from global leaders in antimicrobial stewardship as they share their efforts to combat antimicrobial resistance in resource-limited settings. Jason Newland founded and has led the stewardship conference since its inception. Despite its growth over time, it has retained his warmth, friendliness, and good humor. As Jason gradually transitions leadership of the conference into new hands, we are so grateful for his example and are honored to continue in the tradition that he started. Jason – thank you for building this collaborative, educational, and exceptionally fun meeting. We also want to thank the conference planning committee, Cindy Terrill, Lori Barganier, Michelle Padgett and the Washington University CME team, and The Pediatric Infectious Diseases Society for the support they provide to make this conference possible. The 15th Annual International Pediatric Antimicrobial Stewardship Conference will be held May 28-30, 2025, in St. Louis, Missouri. We hope to see you then! Evan E. Facer, DO, St. Louis Children’s Hospital, St. Louis, MO; Jason G. Newland, MD, MEd, Nationwide Children’s Hospital, Columbus, OH; Rebecca G. Same, MD, Children’s Hospital of Philadelphia, PA

Journal of the Pediatric Infectious Diseases SocietyVol. 13(Supplement_3)
Pfizer, Children's Hospital Colorado, Georgia Clinical and Translational Science Alliance, Academic Pediatric Association, National Institutes of Health, National Center for Advancing Translational Sciences
Openalex Percentile: Top 70%
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.